Clinical Trial Detail

NCT ID NCT01397734
Title Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements no
Sponsors Beth Israel Deaconess Medical Center
Indications

chronic myeloid leukemia

Therapies

Arsenic trioxide

Age Groups: adult

No variant requirements are available.